Pharma Nord was founded in 1982 by the current owner, Eli Wallin and Sven Moesgaard. They established import of a selenium product from England. Soon after, the product was developed and ended up as Bio-Selenium+Zinc. Today, this product is still a cornerstone of the product range.
The underlying idea of Pharma Nord was to compensate for the shortcomings of modern diet by means of dietary supplements with high bioavailability and a documented effect. Bio-Selenium+Zinc successfully embedded this philosophy. A single product soon established the first daughter companies in Sweden, England and Finland.
Over the years, Pharma Nord has earned a reputation as an innovative and visionary player within its field on several occasions. Pharma Nord was the first company to introduce coenzyme Q10 to the European market. The launch of Bio-Quinone Q10 in 1990 has seen the product grow to become one of the leading Q10 products worldwide.